← The Wire
INDVNasdaq
Indivior Pharmaceuticals, Inc.
Pharmaceutical Preparations · DE · CIK 1625297
Indivior Pharmaceuticals develops and markets addiction treatment and mental health products
red 8-K · 90d
$4.55B
Market cap
$41.26
Last close
-1.4%
1D
+7.7%
5D
2.6M
Volume
Price · last 39 sessions+5.8%
May 4L $33.71 · H $41.83Jun 29
384
Total filings
May 15, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteMay 15, 20268-KReg FD Disclosure · Company UpdateMay 4, 202610-Q10-QApr 30, 20268-KResults of Operations · Reg FD DisclosureApr 30, 2026DEFA14ADEFA14AMar 27, 2026DEF 14ADEF 14AMar 27, 20268-KMaterial Agreement · Agreement TerminatedMar 17, 20268-KCompany UpdateMar 13, 20268-KCompany UpdateMar 12, 202610-K10-KFeb 26, 20268-KResults of Operations · Reg FD DisclosureFeb 26, 20268-KChange of Control · Executive ChangeJan 26, 20268-KReg FD DisclosureJan 8, 2026SC 13D/ASC 13D/ADec 30, 2025SC 13D/ASC 13D/ADec 23, 20258-KReg FD DisclosureDec 22, 20258-KExecutive ChangeDec 18, 20258-KBylaw Amendment · Shareholder VoteDec 15, 2025SC 13D/ASC 13D/ADec 10, 20258-KAgreement Terminated · Reg FD DisclosureNov 20, 20258-KReg FD DisclosureNov 14, 20258-K/AExit / Disposal CostsOct 30, 202510-Q10-QOct 30, 20258-KResults of Operations · Reg FD DisclosureOct 30, 20258-KReg FD DisclosureOct 1, 20258-KExit / Disposal CostsAug 26, 20258-KExecutive ChangeAug 22, 20258-K/AExecutive ChangeAug 4, 202510-Q10-QJul 31, 20258-KResults of Operations · Reg FD DisclosureJul 31, 20258-KReg FD DisclosureJun 30, 20258-KExecutive Change · Company UpdateJun 24, 20258-KReg FD DisclosureJun 2, 20258-KCompany UpdateJun 2, 20258-K/AShareholder VoteMay 12, 20258-KExecutive Change · Bylaw AmendmentMay 8, 202510-Q10-QMay 1, 20258-KResults of OperationsApr 24, 20258-KReg FD DisclosureMar 27, 20258-KExecutive Change · Material AgreementMar 4, 202510-K10-KMar 3, 20256-KTOTAL VOTING RIGHTSMar 3, 20256-KDIRECTOR/PDMR SHAREHOLDINGFeb 28, 20256-KDIRECTOR/PDMR SHAREHOLDINGFeb 28, 20256-KHOLDING(S) IN COMPANYFeb 28, 20256-KDIRECTOR/PDMR SHAREHOLDINGFeb 27, 20256-KDIRECTOR/PDMR SHAREHOLDINGFeb 27, 20256-KJOSEPH CIAFFONI APPOINTED CHIEF EXECUTIVE OFFICERFeb 27, 20256-KHOLDING(S) IN COMPANYFeb 25, 20256-KFDA APPROVAL OF SUBLOCADE LABEL CHANGESFeb 24, 20256-K6-KFeb 20, 20256-KDELAYED FDA APPROVAL OF SUBLOCADE LABEL CHANGESFeb 12, 20256-KNOTICE OF RESULTSFeb 4, 20256-KCOMPLETION OF SHARE REPURCHASE PROGRAMFeb 4, 20256-KTRANSACTION IN OWN SHARESFeb 4, 20256-KTOTAL VOTING RIGHTSFeb 3, 20256-KAPPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORFeb 3, 20256-KDR. DAVID WHEADON APPOINTED CHAIR OF THE BOARDJan 28, 20256-KHOLDING(S) IN COMPANYJan 28, 20256-KTRANSACTION IN OWN SHARESJan 28, 20256-KHOLDING(S) IN COMPANYJan 27, 20256-KTRANSACTION IN OWN SHARESJan 21, 20256-KTRANSACTION IN OWN SHARESJan 14, 20256-KINDIVIOR PROVIDES HISTORICAL FINANCIALS IN US GAAPJan 10, 20256-KHOLDING(S) IN COMPANYJan 7, 20256-KTRANSACTION IN OWN SHARESJan 7, 20256-KTOTAL VOTING RIGHTSJan 2, 20256-KHOLDING(S) IN COMPANYDec 31, 20246-KTRANSACTION IN OWN SHARESDec 31, 20246-KTRANSACTION IN OWN SHARESDec 26, 20246-KDIRECTOR/PDMR SHAREHOLDINGDec 23, 20246-KINDIVIOR ANNOUNCES CHANGES TO BOARD OF DIRECTORSDec 17, 20246-KTRANSACTION IN OWN SHARESDec 17, 20246-KTRANSACTION IN OWN SHARESDec 10, 20246-KTRANSACTION IN OWN SHARESDec 3, 20246-KTOTAL VOTING RIGHTSDec 2, 20246-KTRANSACTION IN OWN SHARESNov 26, 20246-KINDIVIOR TO PARTICIPATE IN UPCOMING INVESTOR EVENTNov 22, 20246-KTRANSACTION IN OWN SHARESNov 19, 20246-KHOLDING(S) IN COMPANYNov 18, 2024
Insider Activity
◆ Cluster Buy · 6 insidersIn the 90 days to Mar 13, 2026: 6 insiders bought $204K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 13, 2026 | Ryan BarbaraDirector | Buy | 8 | $31.09 | $249 |
| Mar 9, 2026 | Ryan BarbaraDirector | Buy | 31 | $32.56 | $1K |
| Mar 6, 2026 | Kingsley Stuart ADirector | Buy | 940 | $31.87 | $30K |
| Jan 5, 2026 | Wheadon David E.Director | Buy | 1,771 | $35.39 | $63K |
| Jan 5, 2026 | Humphreys KeithDirector | Buy | 775 | $35.39 | $27K |
| Jan 5, 2026 | Ninivaggi Daniel ADirector | Buy | 775 | $35.39 | $27K |
| Jan 5, 2026 | Stejbach MarkDirector | Buy | 775 | $35.39 | $27K |
| Jan 5, 2026 | Ryan BarbaraDirector | Buy | 775 | $35.39 | $27K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance